Brainstorm Cell Therapeutics(BCLI) - 2022 Q3 - Earnings Call Transcript

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2022 Earnings Conference Call November 14, 2022 8:00 AM ET Company Participants Michael Wood - LifeSci Advisors Chaim Lebovits - President and CEO Stacy Lindborg - EVP and Chief Development Officer Ralph Kern - President and Chief Medical Officer Alla Patlis - Interim CFO Conference Call Participants David Bautz - Zacks Small-Cap Daniel Walker - Ness Industries Operator Greetings, and welcome to the Brainstorm Cell Therapeutics Third Quarter 2022 Conference ...